ArticleAnnals of hematology2026

Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.

Cuicui Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.